Paper41345286
Defective vascular smooth muscle cell tafazzin impairs mitochondrial function and promotes atherosclerosis in preclinical models.
Dong C and 13 others. Nat Commun, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Defective vascular smooth muscle cell tafazzin impairs mitochondrial function and promotes atherosclerosis in preclinical models. Papers, record 41345286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41345286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Defective vascular smooth muscle cell tafazzin impairs mitochondrial function and promotes atherosclerosis in preclinical models.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| Muscle, Smooth, Vascular | Major topic |
| Mitochondria | Major topic |
| Acyltransferases | Major topic |
| Myocytes, Smooth Muscle | Major topic |
| Transcription Factors | Major topic |
| Animals | |
| Cardiolipins | |
| MicroRNAs | |
| Humans | |
| Mice | |
| Apoptosis | |
| Lipoproteins, LDL | |
| Plaque, Atherosclerotic | |
| Male | |
| Disease Models, Animal | |
| NF-kappa B | |
| Mice, Inbred C57BL |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RE/24/130011 | British Heart Foundation (BHF) | PubMed | ||
| MC_UU_00028/4 | RCUK | Medical Research Council (MRC) | PubMed | ||
| MC_UU_00028/5 | Wellcome Trust (Wellcome) | PubMed | ||
| RG71070, RG84554, Centre of Research Excellence | British Heart Foundation (BHF) | PubMed | ||
| RG71070, RG84554 | British Heart Foundation (BHF) | PubMed | ||
| 220257/Z/20/Z | Wellcome Trust (Wellcome) | PubMed | ||
| FS/19/2/34017 | British Heart Foundation (BHF) | PubMed | ||
| Wellcome Trust | United Kingdom | PubMed | ||
| 146281 | DH | National Institute for Health Research (NIHR) | PubMed |
Source PubMed
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26892967 | Vascular Smooth Muscle Cells in Atherosclerosis. | Circ Res | 2016 | https://conductscience.org/library/papers/26892967 | PubMed |
| 2 | 31764100 | MicroRNA biomarkers associated with type 1 myocardial infarction in HIV-positive individuals. | AIDS | 2019 | https://conductscience.org/library/papers/31764100 | PubMed |
| 3 | 16341221 | Dosage compensation of the active X chromosome in mammals. | Nat Genet | 2006 | https://conductscience.org/library/papers/16341221 | PubMed |
| 4 | 21091282 | Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency. | Hum Gene Ther | 2011 | https://conductscience.org/library/papers/21091282 | PubMed |
| 5 | 30727757 | Promoters to Study Vascular Smooth Muscle. | Arterioscler Thromb Vasc Biol | 2019 | https://conductscience.org/library/papers/30727757 | PubMed |
| 6 | 33077895 | A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism. | Genet Med | 2021 | https://conductscience.org/library/papers/33077895 | PubMed |
| 7 | 21068380 | Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21068380 | PubMed |
| 8 | 31411562 | Neuronal TORC1 modulates longevity via AMPK and cell nonautonomous regulation of mitochondrial dynamics in C. elegans. | Elife | 2019 | https://conductscience.org/library/papers/31411562 | PubMed |
| 9 | 31359001 | Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. | Nat Med | 2019 | https://conductscience.org/library/papers/31359001 | PubMed |
| 10 | 10625622 | Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor, I-kappaB. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10625622 | PubMed |
| 11 | 15690088 | 5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15690088 | PubMed |
| 12 | 22023389 | The cellular and molecular mechanisms for neutropenia in Barth syndrome. | Eur J Haematol | 2012 | https://conductscience.org/library/papers/22023389 | PubMed |
| 13 | 29643057 | Defective Base Excision Repair of Oxidative DNA Damage in Vascular Smooth Muscle Cells Promotes Atherosclerosis. | Circulation | 2018 | https://conductscience.org/library/papers/29643057 | PubMed |
| 14 | 16428340 | Rapamycin antagonizes NF-kappaB nuclear translocation activated by TNF-alpha in primary vascular smooth muscle cells and enhances apoptosis. | Am J Physiol Heart Circ Physiol | 2006 | https://conductscience.org/library/papers/16428340 | PubMed |
| 15 | 24902970 | Mechanisms of plaque formation and rupture. | Circ Res | 2014 | https://conductscience.org/library/papers/24902970 | PubMed |
| 16 | 32962412 | Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human. | Circulation | 2020 | https://conductscience.org/library/papers/32962412 | PubMed |
| 17 | 20887898 | Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. | Cell | 2010 | https://conductscience.org/library/papers/20887898 | PubMed |
| 18 | 38871974 | SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome. | Sci Rep | 2024 | https://conductscience.org/library/papers/38871974 | PubMed |
| 19 | 32554501 | Mitochondrial protein interaction landscape of SS-31. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32554501 | PubMed |
| 20 | 20703300 | Mammalian microRNAs predominantly act to decrease target mRNA levels. | Nature | 2010 | https://conductscience.org/library/papers/20703300 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42921408 | A chronological framework for atherosclerosis: from environmental pressure to clinical disease, with vascular aging as a cross-cutting dimension. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42921408 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TAFAZZIN | 6901 | PubTator's text mining | https://conductscience.org/library/genes/6901 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41345286
GET https://conductscience.org/api/papers/v1/41345286/references?page=2